Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$279.76
-1.9%
$328.31
$261.59
$473.50
$7.98B0.87201,427 shs43,854 shs
Revvity, Inc. stock logo
PKI
Revvity
$127.73
$113.46
$170.00
$14.57B1.1851,117 shs1.63 million shs
Bio-Techne Co. stock logo
TECH
Bio-Techne
$62.82
-1.4%
$70.35
$51.79
$89.91
$9.87B1.221.06 million shs152,695 shs
Waters Co. stock logo
WAT
Waters
$309.20
-1.3%
$335.49
$231.90
$363.80
$18.34B0.92405,438 shs112,153 shs
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
+2.04%-2.47%-18.50%-9.77%-38.15%
Revvity, Inc. stock logo
PKI
Revvity
0.00%0.00%0.00%0.00%-14.55%
Bio-Techne Co. stock logo
TECH
Bio-Techne
+1.42%-0.50%-10.92%-10.37%-24.27%
Waters Co. stock logo
WAT
Waters
+4.71%-0.12%-9.78%+0.29%+1.03%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
4.6995 of 5 stars
3.44.00.04.21.83.31.9
Revvity, Inc. stock logo
PKI
Revvity
4.1898 of 5 stars
3.50.01.73.50.01.74.4
Bio-Techne Co. stock logo
TECH
Bio-Techne
4.9752 of 5 stars
4.42.01.74.22.72.53.1
Waters Co. stock logo
WAT
Waters
2.7337 of 5 stars
0.92.00.03.41.22.52.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
2.80
Moderate Buy$468.0067.29% Upside
Revvity, Inc. stock logo
PKI
Revvity
3.00
Buy$115.50∞ Upside
Bio-Techne Co. stock logo
TECH
Bio-Techne
2.80
Moderate Buy$83.9033.56% Upside
Waters Co. stock logo
WAT
Waters
1.88
Reduce$298.67-3.41% Downside

Current Analyst Ratings

Latest BIO, TECH, PKI, and WAT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/18/2024
Bio-Techne Co. stock logo
TECH
Bio-Techne
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$85.00 ➝ $82.00
4/4/2024
Waters Co. stock logo
WAT
Waters
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetIn-Line ➝ In-Line$320.00 ➝ $340.00
4/3/2024
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$400.00 ➝ $365.00
2/16/2024
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$395.00 ➝ $420.00
2/16/2024
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$484.00 ➝ $480.00
2/12/2024
Waters Co. stock logo
WAT
Waters
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetUnderweight ➝ Underweight$275.00 ➝ $300.00
2/8/2024
Bio-Techne Co. stock logo
TECH
Bio-Techne
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageSector Outperform$80.00
2/7/2024
Waters Co. stock logo
WAT
Waters
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$290.00 ➝ $330.00
2/2/2024
Bio-Techne Co. stock logo
TECH
Bio-Techne
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$92.00 ➝ $87.00
2/2/2024
Bio-Techne Co. stock logo
TECH
Bio-Techne
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSector Perform ➝ Sector Perform$85.00 ➝ $75.00
2/2/2024
Bio-Techne Co. stock logo
TECH
Bio-Techne
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold$65.00
(Data available from 4/24/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$2.67B2.99$12.09 per share23.14$306.51 per share0.91
Revvity, Inc. stock logo
PKI
Revvity
$3.31B0.00N/A9.88$58.49 per share0.00
Bio-Techne Co. stock logo
TECH
Bio-Techne
$1.14B8.69$2.52 per share24.96$12.49 per share5.03
Waters Co. stock logo
WAT
Waters
$2.96B6.20$15.08 per share20.51$19.45 per share15.90

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
-$637.32M-$21.49N/A24.41N/A-23.86%3.90%2.77%5/7/2024 (Confirmed)
Revvity, Inc. stock logo
PKI
Revvity
$569.18M$7.6815.010.000.5028.94%11.17%5.83%N/A
Bio-Techne Co. stock logo
TECH
Bio-Techne
$285.26M$1.3845.5234.717.8119.58%14.21%10.36%5/1/2024 (Confirmed)
Waters Co. stock logo
WAT
Waters
$642.23M$10.8528.5023.575.9521.72%81.30%16.41%5/7/2024 (Confirmed)

Latest BIO, TECH, PKI, and WAT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024N/A
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$2.04N/A-$2.04N/AN/AN/A  
5/7/2024N/A
Waters Co. stock logo
WAT
Waters
$2.09N/A-$2.09N/AN/AN/A  
5/1/2024N/A
Bio-Techne Co. stock logo
TECH
Bio-Techne
$0.40N/A-$0.40N/AN/AN/A  
2/15/2024Q4 2023
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$2.93$3.10+$0.17-$5.94$685.00 million$681.18 million      
2/6/2024Q4 2023
Waters Co. stock logo
WAT
Waters
$3.56$3.62+$0.06$3.59$815.50 million$819.50 million    
2/1/2024Q2 2024
Bio-Techne Co. stock logo
TECH
Bio-Techne
$0.36$0.33-$0.03$0.49$277.48 million$272.60 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
N/AN/AN/AN/AN/A
Revvity, Inc. stock logo
PKI
Revvity
$0.28N/AN/A3.65%N/A
Bio-Techne Co. stock logo
TECH
Bio-Techne
$0.320.51%+151.98%23.19%N/A
Waters Co. stock logo
WAT
Waters
N/AN/AN/AN/AN/A

Latest BIO, TECH, PKI, and WAT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/1/2024
Bio-Techne Co. stock logo
TECH
Bio-Techne
quarterly$0.080.5%2/9/20242/12/20242/26/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
0.14
5.83
4.34
Revvity, Inc. stock logo
PKI
Revvity
0.48
2.43
2.15
Bio-Techne Co. stock logo
TECH
Bio-Techne
0.23
4.37
3.03
Waters Co. stock logo
WAT
Waters
2.00
2.22
1.57

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
65.24%
Revvity, Inc. stock logo
PKI
Revvity
85.22%
Bio-Techne Co. stock logo
TECH
Bio-Techne
98.95%
Waters Co. stock logo
WAT
Waters
94.01%

Insider Ownership

CompanyInsider Ownership
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
17.50%
Revvity, Inc. stock logo
PKI
Revvity
0.52%
Bio-Techne Co. stock logo
TECH
Bio-Techne
4.10%
Waters Co. stock logo
WAT
Waters
0.82%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
8,03028.52 million23.53 millionOptionable
Revvity, Inc. stock logo
PKI
Revvity
16,700126.41 million125.76 millionOptionable
Bio-Techne Co. stock logo
TECH
Bio-Techne
3,050157.19 million150.75 millionOptionable
Waters Co. stock logo
WAT
Waters
7,90059.31 million58.82 millionOptionable

BIO, TECH, PKI, and WAT Headlines

SourceHeadline
New York State Common Retirement Fund Has $68.70 Million Stock Position in Waters Co. (NYSE:WAT)New York State Common Retirement Fund Has $68.70 Million Stock Position in Waters Co. (NYSE:WAT)
marketbeat.com - April 24 at 8:44 AM
Young great white sharks along Southern California coast prefer warm, shallow waters, study showsYoung great white sharks along Southern California coast prefer warm, shallow waters, study shows
msn.com - April 24 at 8:36 AM
2026 4-star CB Jaelen Waters commits to Florida State Seminoles2026 4-star CB Jaelen Waters commits to Florida State Seminoles
msn.com - April 23 at 10:36 PM
Area waters to close shrimping for 1 month beginning in MayArea waters to close shrimping for 1 month beginning in May
msn.com - April 23 at 10:36 PM
Arizona Wildcats guard KJ Lewis testing NBA Draft waters, will maintain college eligibilityArizona Wildcats guard KJ Lewis testing NBA Draft waters, will maintain college eligibility
arizonasports.com - April 23 at 5:35 PM
First-of-its-kind study shows how juvenile Great White sharks choose their habitat watersFirst-of-its-kind study shows how juvenile Great White sharks choose their habitat waters
msn.com - April 23 at 5:35 PM
HCSO launches Operation Safe Waters with 2 new high-tech vesselsHCSO launches Operation Safe Waters with 2 new high-tech vessels
msn.com - April 23 at 5:35 PM
Sunny day flooding increases fecal contamination of coastal waters'Sunny day flooding' increases fecal contamination of coastal waters
msn.com - April 23 at 5:35 PM
‘As if a cathedral had been flooded with turquoise waters’: The Spanish hotel where Gothic and stained glass meet time off in the sun‘As if a cathedral had been flooded with turquoise waters’: The Spanish hotel where Gothic and stained glass meet time off in the sun
countrylife.co.uk - April 23 at 12:34 PM
Government Regulation Hits Rural Landowner As Feds Claim Dry Ditch Is “Waters of US”Government Regulation Hits Rural Landowner As Feds Claim Dry Ditch Is “Waters of US”
agweb.com - April 23 at 12:34 PM
Waters (NYSE:WAT) Shares Gap Up to $299.23Waters (NYSE:WAT) Shares Gap Up to $299.23
marketbeat.com - April 23 at 12:10 PM
3,600 Shares in Waters Co. (NYSE:WAT) Bought by Louisiana State Employees Retirement System3,600 Shares in Waters Co. (NYSE:WAT) Bought by Louisiana State Employees Retirement System
marketbeat.com - April 23 at 4:51 AM
ATHLETE OF THE WEEK: Nolan Waters, senior, Atlantic boys tennisATHLETE OF THE WEEK: Nolan Waters, senior, Atlantic boys tennis
swiowanewssource.com - April 23 at 2:34 AM
JT Toppin to test the NBA Draft watersJT Toppin to test the NBA Draft waters
kob.com - April 23 at 2:34 AM
4.6 magnitude earthquake hits waters off Hinatuan in Surigao del Sur4.6 magnitude earthquake hits waters off Hinatuan in Surigao del Sur
msn.com - April 23 at 2:34 AM
Enterprise soccer duo Lascano, Waters sign college scholarshipsEnterprise soccer duo Lascano, Waters sign college scholarships
dothaneagle.com - April 22 at 9:33 PM
Turning 78 today, John Waters recalls his show business start as a puppeteerTurning 78 today, John Waters recalls his show business start as a puppeteer
baltimorefishbowl.com - April 22 at 9:33 PM
Lake sturgeon, giants of Minnesota waters, wont land on endangered species listLake sturgeon, giants of Minnesota waters, won't land on endangered species list
msn.com - April 22 at 9:33 PM
Coast Guard Region 4: Military-civilian ties in Southwestern watersCoast Guard Region 4: Military-civilian ties in Southwestern waters
en.qdnd.vn - April 22 at 3:29 PM
Thames Waters wants to hike up bills by 60% in bid to stave off financial strifeThames Waters wants to hike up bills by 60% in bid to stave off financial strife
mirror.co.uk - April 22 at 3:29 PM
Waters Corporation: Waters Accelerates the Development of Gene-based Therapeutics with New GTxResolve Premier SEC ColumnsWaters Corporation: Waters Accelerates the Development of Gene-based Therapeutics with New GTxResolve Premier SEC Columns
finanznachrichten.de - April 22 at 10:28 AM
US Open Features thousands Of Amateurs And Doubles From Waters And JohnsonUS Open Features thousands Of Amateurs And Doubles From Waters And Johnson
forbes.com - April 22 at 10:28 AM
ERISA complaint against Waters Corp. 401(k) plan survives motion to dismissERISA complaint against Waters Corp. 401(k) plan survives motion to dismiss
pionline.com - April 22 at 10:28 AM
Disgusting depravity: What is John Waters’ grossest movie?Disgusting depravity: What is John Waters’ grossest movie?
faroutmagazine.co.uk - April 22 at 10:28 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Bio-Rad Laboratories logo

Bio-Rad Laboratories

NYSE:BIO
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Revvity logo

Revvity

NYSE:PKI
Revvity, Inc provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics.? The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937, and is headquartered in Waltham, MA.
Bio-Techne logo

Bio-Techne

NASDAQ:TECH
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets in the United States, the United Kingdom, rest of Europe, Middle East, and Africa, Greater China, rest of Asia-Pacific, and internationally. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.
Waters logo

Waters

NYSE:WAT
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.